Vascular adverse events under long-term nilotinib therapy in patients with chronic myeloid leukemia
Publication date: Available online 1 August 2017 Source:Clinical Lymphoma Myeloma and Leukemia Author(s): Ahmet Emre Eskazan
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Leukemia | Lymphoma | Myeloma | Nilotinib | Tasigna